|
||
| |||||||
|
|
New specialist service division at VWRI to provide customer-facing support for Geneservice, the leading genomic contract research organization. 27 February 2006, Cambridge, UK - Geneservice Ltd, today announced a five-year strategic alliance with VWRI for sales representation of the companies leading contract research platforms. Customers in Europe, USA and the UK will now be able to access industry leading genotyping, gene expression and DNA handling capabilities at Geneservice via their local VWR specialist service representative. VWR’s sales and marketing operation currently serves over 250,000 customers with an extensive worldwide specialist sales network This strategically important agreement, the first since the management buyout of MRC Geneservice in 2005, is further evidence of Geneservice’s commitment to providing the very latest discovery contract research platforms to a growing customer base. Tom Weaver, CEO at Geneservice commented ‘Our new alliance with VWRI is strategically important for us. It significantly increases our geographical coverage and makes our leading contract research platforms available to more researchers worldwide. We are delighted to have been selected by VWR to be one of the first companies to be included in the VWR Bioscience programme’ The alliance offers an excellent balance and fit between Geneservice’s established expertise in genomic contract research and VWR’s marketing capabilities, global market strength and representation. Geneservice customers will benefit from the proximity with their local VWR specialist service representative, and will have direct access to leading technology and a team of dedicated, highly qualified scientists with extensive project management experience at Geneservice. With over 10 years experience as a national genomics core laboratory and bioinformatics infrastructure, Geneservice has both the capacity and ambition to move beyond the UK market. Working with VWR will substantially increase Geneservice’s exposure by promoting its expert contract research program and customer service to academic, clinical, government, biotech and pharma labs world-wide. Dr. Weaver also highlighted that “Working with VWR in setting up this alliance has been terrific, and it has been more like partnering with another small start-up company instead of what is in reality a very large corporation. This has facilitated our ability to move quickly and effectively, and I believe this says a lot about VWR Biosciences innovative management team. Even though selling services will be a new challenge for VWR reps, so far there has been excellent communication with our scientists and shared vision on how to make this venture a success and swiftly grow the business” VWR International is a global distributor providing a diversified range of products and has recently established VWR Biosciences to provide specialist services, such as those provided by Geneservice, to the bioscience and lifescience industries. VWR’s primary customers work in the pharmaceutical, life science, chemical, technology, food processing and consumer product industry throughout North America and Europe. Zishan Haroon, CEO of VWR Biosciences commented ‘Geneservice is an industry leading genomic service provider and we are pleased to have been chosen by them for this important alliance. The VWRI biosciences team is looking forward to presenting the extensive range of contract research to our growing customer base’ -TEXT ENDS- Contact: Tom Weaver , CEO or Roger Turner, Finance and Commercial Director
Geneservice Ltd About Geneservice Geneservice Ltd was launched in August 2005 following a successful management buyout of the UK Medical Research Council Biological Resource Centre (MRC Geneservice). Geneservice offers access to high quality genomic products and leading contract research for applications in the lifesciences, clinical research and development. For more information visit www.geneservice.co.uk
|
|
| ||||||||
